XENOGRAFT EXPANDED FANG AUTOLOGOUS TUMOR CELL VACCINE DEVELOPMENT AND MANUFACTURING FOR CLINICAL USE
Expanded FANG Autologous Tumor Cell Vaccine Development and Manufacturing for Clinical Use.
Archive for Publications
PHASE I/II STUDY OF ONCOLYTIC HERPES SIMPLEX VIRUS NV1020 IN PATIENTS WITH EXTENSIVELY PRETREATED REFRACTORY COLORECTAL CANCER METASTATIC TO THE LIVER
Phase I/II Study of Oncolytic Herpes Simplex Virus NV1020 in Patients with Extensively Pretreated Refractory Colorectal Cancer Metastatic to the Liver.
POTENTIAL USE OF RNA INTERFERENCE IN CANCER THERAPY
Potential Use of RNA Interference in Cancer Therapy. Expert Reviews in Molecular Medicine 2010 Aug 18; 12(e26):1-16.
PRECLINICAL SAFETY AND TOXICITY ASSESSMENT OF STATHMIN 1 BIFUNCTIONAL SHRNA FORMULATION
Preclinical safety and toxicity assessment of Stathmin 1 bifunctional shRNA formulation following a single intravenous injection in rats. Poster #252. ASGCT 13th Annual Meeting, May 17 – 22, 2010, Washington, D.C.
REGULATORY SUBMISSION PROCESS FOR GENE AND CELLULAR THERAPIES
Regulatory Submission Process for Gene and Cellular Therapies.
REMOVAL OF CLINICALLY RELEVANT CONTAMINANTS FROM CGMP GRADE PREPARATIONS OF PLASMID DNA: IMPLICATIONS FOR NON-VIRAL GENE THERAPY AND DNA-BASED VACCINES
Removal of clinically relevant contaminants from cGMP grade preparations of plasmid DNA: implications for non-viral gene therapy and DNA-based vaccines.
SIPULEUCEL-T IMMUNOTHERAPY FOR CASTRATION-RESISTANT PROSTATE CANCER
Frohlich MW, Schellhammer PF, for the IMPACT Study Investigators: Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer.
TAG VACCINE CLINICAL TRIAL MANUFACTURING
Vaccine Clinical Trial Manufacturing.
CURRENT VACCINE UPDATES FOR LUNG CANCER
Current Vaccine Updates for Lung Cancer. Expert Review of Vaccines 2010 Mar; 9(3):323-335.
ENHANCED TARGET GENE KNOCKDOWN BY A BIFUNCTIONAL SHRNA: A NOVEL APPROACH OF RNA INTERFERENCE
Enhanced Target Gene Knockdown by a Bifunctional shRNA: A Novel Approach of RNA Interference.